Xoma | XOMA - Capitaux Propres Et Réserves



Capitaux Propres Et Réserves Changement Date
AbbVie USD -5.94B 721M 2026-06
Agenus USD -199.08M 22.15M 2026-06
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
aTyr Pharma USD 48.79M 9.15M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Celldex Therapeutics USD 714.56M 258.34M 2026-06
Curis USD 12.71M 7.24M 2026-03
Eli Lilly USD 33.88B 2.68B 2026-06
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Incyte USD 6.34B 721.58M 2026-06
MacroGenics USD 42.87M 21.68M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 85.19B 4.91B 2026-06
Prothena USD 286.89M 25.72M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06